financetom
Business
financetom
/
Business
/
C3.ai Shares Up 20% Since Monday's Open After Earnings Slide
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
C3.ai Shares Up 20% Since Monday's Open After Earnings Slide
Mar 11, 2026 6:14 AM

C3.ai Inc ( AI ) shares are climbing again Tuesday afternoon, extending a sharp rebound that has the stock up roughly 20% since Monday's open after tumbling to a 52-week low last week in the wake of its earnings report. Here's what you need to know.

C3.ai ( AI ) stock is among today’s top performers. What’s fueling AI momentum?

New CEO Bets On C3.ai Enterprise Edge

The move higher comes after C3.ai ( AI ) last week reported a wider-than-expected adjusted third-quarter loss of 40 cents per share on revenue of $53.26 million, well below Wall Street forecasts and down sharply from $98.78 million a year earlier.

Management also launched a restructuring that includes workforce reductions and slashed its fiscal 2026 revenue outlook to about $247 million to $251 million, roughly half its prior guidance and far short of earlier analyst expectations.

New CEO Stephen Ehikian said he remains convinced C3.ai ( AI ) is uniquely positioned to win in enterprise AI but acknowledged the company was not previously organized to execute on that opportunity.

Geopolitical Tensions Could Boost Demand For AI

As geopolitical tensions escalate in the Middle East, AI platforms used in defense, cybersecurity and risk analysis could potentially see stronger demand, even as broader markets remain choppy.

C3.ai's ( AI ) rebound Tuesday highlights how certain AI names may still find support during periods of geopolitical turmoil, with the sector viewed as a possible beneficiary of increased focus on security and data-driven decision-making.

C3.ai’s Bearish Technical Momentum

C3.ai ( AI ) shares traded as high as about $29 over the past year but have steadily trended lower, recently hitting a low near $8 last week.

The 20-, 50- and 200-day moving averages all slope downward, underscoring persistent bearish momentum in the stock over the past year.

AI Shares Gain 6% Tuesday

AI Price Action: C3.ai ( AI ) shares were up 6.36% at $9.20 at the time of publication on Tuesday, according to Benzinga Pro data.

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Luna Innovations Names William Phelan as Financial, Accounting Chief
Luna Innovations Names William Phelan as Financial, Accounting Chief
Oct 17, 2024
05:58 PM EDT, 10/16/2024 (MT Newswires) -- Luna Innovations ( LUNA ) said late Wednesday that William L. Phelan was appointed as its chief financial officer and chief accounting officer with immediate effect. Phelan succeeds John Roiko, who, the company said, will move to a consulting role to support the ongoing restatement process. Before joining Luna, Phelan was the chief...
MongoDB to Redeem $1.15 Billion Notes Due 2026
MongoDB to Redeem $1.15 Billion Notes Due 2026
Oct 17, 2024
05:57 PM EDT, 10/16/2024 (MT Newswires) -- MongoDB ( MDB ) said late Wednesday that it issued a notice of redemption for all $1.15 billion of its 0.25% convertible senior notes due 2026. The redemption price equals 100% of the principal amount plus accrued and unpaid interest. The redemption date is Dec. 16, and holders may convert the notes at...
Lexicon Pharmaceuticals to Get $25 Million From Viatris in Global Sotagliflozin Licensing Deal
Lexicon Pharmaceuticals to Get $25 Million From Viatris in Global Sotagliflozin Licensing Deal
Oct 17, 2024
05:53 PM EDT, 10/16/2024 (MT Newswires) -- Lexicon Pharmaceuticals ( LXRX ) will get an upfront payment of $25 million from Viatris ( VTRS ) for an exclusive license to commercialize sotagliflozin outside of the US and Europe in all indications. Sotagliflozin is a medication used to reduce the risk of death and hospitalization in adults with heart failure or...
Equifax sees 2024 revenue below estimates amid mortgage market slump
Equifax sees 2024 revenue below estimates amid mortgage market slump
Oct 17, 2024
(Reuters) - Credit ratings firm Equifax ( EFX ) said on Wednesday it expects full-year revenue below Wall Street estimates, as higher-for-longer interest rates continued to weigh on loan demand and kept the mortgage market stagnant, sending shares down 5% after the bell.   Even as the U.S. Federal Reserve delivered its first rate cut in four years in late...
Copyright 2023-2026 - www.financetom.com All Rights Reserved